These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19657486)

  • 1. Recommendations for the use of albumin and immunoglobulins.
    Liumbruno GM; Bennardello F; Lattanzio A; Piccoli P; Rossettias G;
    Blood Transfus; 2009 Jul; 7(3):216-34. PubMed ID: 19657486
    [No Abstract]   [Full Text] [Related]  

  • 2. Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?
    Federici AB; Rossi V; Sacchi E; Franchini M
    Blood Transfus; 2012 Jul; 10(3):402-3; author reply 404-5. PubMed ID: 22244008
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential Creutzfeldt-Jakob disease (CJD) exposure: to notify or not to notify.
    Freedman J; Hall A; Dey A
    Transfus Sci; 1997 Sep; 18(3):491-2. PubMed ID: 10175161
    [No Abstract]   [Full Text] [Related]  

  • 4. [The transfusion of blood and its derivatives in the neonate].
    Mercado-Arellano A; Farfán-Canto JM; González-Cabello H; Alvarez-Amaya C; Jasso-Gutiérrez L
    Bol Med Hosp Infant Mex; 1991 Nov; 48(11):836-40. PubMed ID: 1768362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of intravenous immunoglobulins.
    Martin TD
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():514-20. PubMed ID: 10689502
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulins.
    Webster AD
    BMJ; 1991 Aug; 303(6799):375-6. PubMed ID: 1912799
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aseptic meningitis during treatment with very low doses of intravenous immunoglobulins].
    Attout H; Mallet H; Desmurs H; Berthier S; Gil H; de Wazières B; Dupond JL
    Rev Med Interne; 1998 Feb; 19(2):140-1. PubMed ID: 9775133
    [No Abstract]   [Full Text] [Related]  

  • 8. Different batches of human albumin solutions from one manufacturer may induce heterogenous cardiovascular effects.
    Heringlake M; Brückner S; Schmucker P
    Intensive Care Med; 2000 Jul; 26(7):1011-2. PubMed ID: 10990124
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylactoid reaction to human albumin microspheres.
    Littenberg RL
    J Nucl Med; 1975 Mar; 16(3):236-7. PubMed ID: 1113173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
    Gomperts ED; Darr F
    Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects of high-dose intravenous immunoglobulins.
    Stangel M; Hartung HP; Marx P; Gold R
    Clin Neuropharmacol; 1997 Oct; 20(5):385-93. PubMed ID: 9331514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute kidney failure following intravenous administration of high doses of immunoglobulins].
    Cabre P; Smadja D; Odry L; Donikian JC; Vernant JC
    Presse Med; 1994 Jan; 23(3):142. PubMed ID: 8177854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Known and potential risks related to the use of high dose intravenous immunoglobulins].
    Bussel A
    Ann Dermatol Venereol; 1997; 124(5):381-3. PubMed ID: 9739894
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin: adverse reactions and management.
    Bonilla FA
    J Allergy Clin Immunol; 2008 Dec; 122(6):1238-9. PubMed ID: 18842292
    [No Abstract]   [Full Text] [Related]  

  • 15. [About Cochrane and use of albumin].
    Karle H; Hansen NE
    Ugeskr Laeger; 1999 Oct; 161(40):5552-4. PubMed ID: 10553369
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous immunoglobulin: a life-saving (and potentially fatal) treatment.
    Elston DM
    Cutis; 2004 Jun; 73(6):375-6. PubMed ID: 15224778
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new meta-analysis of albumin use in intensive care. Increased mortality is not statistically proved].
    Hahn R
    Lakartidningen; 2001 Oct; 98(43):4689-90. PubMed ID: 11715242
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
    Jankowski A
    Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care personnel alerted to problems with lipid-based products, albumin.
    Am J Health Syst Pharm; 1998 Oct; 55(20):2078-9. PubMed ID: 9988565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.